These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure. van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208 [TBL] [Abstract][Full Text] [Related]
4. Absorption of leucovorin (NSC-3590) from a "mouthwash". Bruckner HW; Bertino JR Cancer Chemother Rep; 1975; 59(3):575-6. PubMed ID: 1081907 [No Abstract] [Full Text] [Related]
5. The metabolism of folinic acid (leucovorin) following oral and parenteral administration. Taguchi H J Nutr Sci Vitaminol (Tokyo); 1981; 27(4):283-90. PubMed ID: 6977022 [TBL] [Abstract][Full Text] [Related]
6. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer. Barlow JJ; Piver MS Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. Vokes EE; Schilsky RL; Weichselbaum RR; Kozloff MF; Panje WR J Clin Oncol; 1990 Feb; 8(2):241-7. PubMed ID: 1688926 [TBL] [Abstract][Full Text] [Related]
8. [Radiational basis and practice of the citrovorum factor (Leucovorin) protection after high-dose methotrexate therapy. High-dose methotrexate/leucovorin]. Sauer H; Schalhorn A Onkologie; 1980 Apr; 3(2):64-71. PubMed ID: 6994007 [TBL] [Abstract][Full Text] [Related]
9. High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer. Greco FA; Fer MF; Richardson RL; Hande KR; Van Boxtel CJ; Oldham RK Cancer Chemother Pharmacol; 1978; 1(4):255-7. PubMed ID: 373922 [TBL] [Abstract][Full Text] [Related]
10. The inability of oral leucovorin to elevate CSF 5-methyl-tetrahydrofolate following high dose intravenous methotrexate therapy. Allen J; Rosen G; Juergens H; Mehta B J Neurooncol; 1983; 1(1):39-44. PubMed ID: 6611387 [TBL] [Abstract][Full Text] [Related]
11. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity. Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784 [No Abstract] [Full Text] [Related]
12. A phase I study of methotrexate administration following 5-fluorouracil. White RM Am J Clin Oncol; 1996 Oct; 19(5):492-9. PubMed ID: 8823478 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine. Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976 [TBL] [Abstract][Full Text] [Related]
14. Serum and cerebrospinal fluid distribution of 5-methyltetrahydrofolate after intravenous calcium leucovorin and intra-Ommaya methotrexate administration in patients with meningeal carcinomatosis. Mehta BM; Glass JP; Shapiro WR Cancer Res; 1983 Jan; 43(1):435-8. PubMed ID: 6600162 [TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a new A.S. mouth wash 881010 as an antismoking agent: a placebo-controlled double-blind trial. Zmeili S; Salhab A; Shubair K; Gharaibeh M; Suliman N; Al-Kayed A; Shubair M; Abu Hijleh N; Abu Jbara M Int J Clin Pharmacol Ther; 1999 Jan; 37(1):41-50. PubMed ID: 10027482 [TBL] [Abstract][Full Text] [Related]
16. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction. Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227 [TBL] [Abstract][Full Text] [Related]
17. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Edelman MJ; Meyers FJ; Houston J; Lauder I Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226 [TBL] [Abstract][Full Text] [Related]
18. Biochemistry of the citrovorum factor rescue effect in normal bone marrow cells after high-dose methotrexate treatment: implications for therapy. Wilmans W; Sauer W; Schalhorn A Recent Results Cancer Res; 1978; 68():33-9. PubMed ID: 313587 [No Abstract] [Full Text] [Related]
19. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue. Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984 [TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Chi KH; Chen CH; Chan WK; Chow KC; Chen SY; Yen SH; Chao JY; Chang CY; Chen KY J Clin Oncol; 1995 Oct; 13(10):2620-8. PubMed ID: 7595716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]